Asceneuron

Clinical-stage biotechnology company developing small molecule therapeutics for neurodegenerative diseases, particularly Alzheimer's disease and other tauopathies.

Location
Lausanne, Switzerland
Founded
2012
Investors
1
Categories
biotech, neuroscience, therapeutics, alzheimers, tauopathies

Investors

NameLocationTypeStagesPortfolio
Novo HoldingsHellerup, Denmarkbiotech-focused
seedseries-a+3
13